Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01244152 · ClinicalTrials.gov registry record · Phase 2
Self-Management in African Americans With Diabetes and Hypertension
A Phase 2 study, sponsored by Rush University Medical Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 59
- Enrollment target
NCT01244152: Completed Phase 2 study, sponsored by Rush University Medical Center.
NCT01244152 is a Phase 2 study that has completed, run by Rush University Medical Center. The registered enrollment target is 59 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (56% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01244152, a Phase 2 study, has completed, sponsored by Rush University Medical Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 59 participants
- Enrollment target
Study Summary
The primary aim of the study is to design a group-based, culturally appropriate self-management skills training intervention for disadvantaged African-Americans with both diabetes and hypertension and to compile an intervention Manual of Operations (MOO). The investigators are developing an intervention to assist individuals in reducing weight and hemoglobin A1c.
Interventions
- BEHAVIORAL Intensive diabetes self-management education
- BEHAVIORAL Enhanced standard diabetes education
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 59 participants |
| Start Date | 2008-07 |
| Est. Completion | 2010-07 |
| Phase | Phase 2 |
What the finished NCT01244152 record still lists
NCT01244152 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 59 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (56% lower).
The record links to 0 conditions, and to 2 interventions - of which Intensive diabetes self-management education is the first listed.
NCT01244152 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01244152 about?
NCT01244152 is a clinical study titled "Self-Management in African Americans With Diabetes and Hypertension". The primary aim of the study is to design a group-based, culturally appropriate self-management skills training intervention for disadvantaged African-Americans with both diabetes and hypertension and to compile an intervention Manual of Operations (MOO). The investigators are developing an interven...
What is the current status of trial NCT01244152?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 59 participants. The study started on 2008-07. Estimated completion is 2010-07.
What interventions are being tested in trial NCT01244152?
The interventions under investigation include: Intensive diabetes self-management education (BEHAVIORAL), Enhanced standard diabetes education (BEHAVIORAL).
Who is sponsoring clinical trial NCT01244152?
This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01244152's enrollment target sits among peer trials
59 1133rd of 2000 higher than 866 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03801083 · 59 participants · Phase 2
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Biliary Tract Cancers
- NCT04332367 · 59 participants · Phase 2
Carboplatin, Taxane And Ramucirumab for Patients With NSCLC After Pemetrexed or Pembrolizumab Maintenance
- NCT05489575 · 59 participants · NA
CPAP for the Treatment of Supine Hypertension
- NCT06721689 · 59 participants · Phase 1
PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia